SLS
SELLAS Life Sciences Group Inc. Common Stock
$1.650+0.000 (0.000%)
Precio en Tiempo Real
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$1.650
Máximo
$1.650
Mínimo
$1.650
Volumen
2.61M
Fundamentos de la Empresa
Estadísticas de Negociación
Noticias Relacionadas
GlobeNewswire
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for
Ver más
GlobeNewswire
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
- ASCO Presentation Supports SLS009 as a Potential Targeted Therapy for ASXL1 Mutated Colorectal Cancer – - 22,500 New Cases of Colorectal Cancer with High Microsatellite Instability per Year in the US: 55% ASXL1m
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.